Confluence Life Sciences
  • Home
  • About Us
  • Our Team
    • Leadership Team
    • Founders & Scientific Advisors
  • News
  • Contact Us

Confluence Awarded Phase 1 SBIR Grant

Posted on May 2, 2013 by clswordpress in Confluence Industry News No Comments

Confluence Life Sciences, Inc., a biotechnology company focused on the rapid discovery and development of kinase inhibitors to treat cancer and inflammatory disease, has been awarded a $289,000 grant to develop new drugs for hard to treat cancers such as pancreatic cancer. The award is a Phase I Small Business Innovation Research (SBIR) grant from [...]

View Post

Confluence Announces $4 Million In Series A Financing

Posted on September 20, 2012 by ConfluenceNews in Confluence Industry News No Comments

St. Louis, MO.  – September 17, 2012 – Confluence Life Sciences, Inc., a biotechnology company focused on the rapid discovery and development of kinase inhibitors to treat cancer and inflammatory disease, today announced a $4 million Series A venture capital financing.  Proceeds from the financing will enable Confluence to advance its product candidates and leverage [...]

View Post

Biotech Funds Take Root in City and County

Posted on June 1, 2011 by ConfluenceNews in Confluence Industry News No Comments

Startups Sprout with Nurturing by BioGenerator, Helix. All a Seedling needs is a little “watering.” And a favorable climate. Biotech companies generally don’t make the same sort of noise that fledgling rock bands do, but they want just as badly to be noticed. For the next big thing in music, it’s a recording contract. For [...]

View Post

Confluence Life Science hires Walter “Wally” Smith

Posted on May 13, 2011 by ConfluenceNews in Confluence Team News No Comments

St. Louis-based Confluence Life Sciences Inc. hired Walter “Wally” Smith as Vice President of Research. Smith has more than 28 years of pharmaceutical industry experience with Searle, Pharmacia and Pfizer. At Pfizer, he served as vice president of research and the company’s global head for the inflammation/immunology therapeutic area. Smith also maintains an active presence [...]

View Post

St. Louis County Finances Bioscience Startups

Posted on April 14, 2011 by ConfluenceNews in Confluence Industry News No Comments

The St. Louis County Economic Council is betting that $1.5 million raised from leasing 56 acres of land to the River City Casino in south St. Louis County will help foster growth in early-stage bioscience companies. The St. Louis County Port Authority, an affiliate of SLCEC, has committed to funding the newly created Helix Fund [...]

View Post

County Invests in New Life Science Firm to Retain Scientists

Posted on March 24, 2011 by ConfluenceNews in Confluence Industry News No Comments

St. Louis County Port Authority, an affiliate of the St. Louis County Economic Council, has invested $50,000 in Confluence Life Sciences, Inc., an early-stage life sciences company developing innovative treatments for animal and human diseases including cancer and chronic inflammatory diseases. Joe Monahan, a highly regarded research scientist with 28 years experience in the drug [...]

View Post

County Invests $50,000 in Life Sciences Company

Posted on March 22, 2011 by ConfluenceNews in Confluence Industry News No Comments

St. Louis County Port Authority, an affiliate of the St. Louis County Economic Council, has invested $50,000 in Confluence Life Sciences Inc., an early-stage life sciences company in Spanish Lake. Research scientist Joe Monahan started the company less than a year ago. Confluence is developing treatments for animal and human diseases including cancer and chronic [...]

View Post

Joe Monahan Secures $50,000 for Confluence Life Sciences, Inc.

Posted on March 11, 2011 by ConfluenceNews in Confluence Team News No Comments

Joe Monahan has secured $50,000 for Confluence Life Sciences Inc., his drug research company, from the Helix Fund, St. Louis County’s $1.5 million kitty that provides seed money for plant and life science startups. Monahan, previously executive director at Pfizer Global Research and Development, has hired nine full- and part-time scientists, said Eric Gulve, president [...]

View Post

New Shared Lab Will Help Sustain Local Research Discoveries

Posted on October 13, 2010 by ConfluenceNews in Confluence Industry News No Comments

Creative business ideas bubble up from underground every day. Making one take flight is a lot more complicated. It takes vision, yes, but it also takes capital. It takes marketing muscle, for sure, but also proof that the idea works. At a time when the nation’s — and the region’s — economies are lurching with [...]

View Post

$1M Lab For Science Startups to Open in St. Louis

Posted on October 12, 2010 by ConfluenceNews in Confluence Industry News No Comments

The Coalition for Plant and Life Sciences will open a new $1 million lab for science start-ups Wednesday at CORTEX, midtown St. Louis’ biotech research district. The 5,400-square-foot BioGenerator Accelerator Labs at 4320 Forest Park Ave. were designed to provide scientists and entrepreneurs at early-stage companies workspace at little or no cost. The experimental facility [...]

View Post

(c) 2012 Confluence Life Sciences, Inc. | 4320 Forest Park Ave Suite 303 | St. Louis MO 63108 USA | Web Design by Sparks Milling Company